Acorah Software Products - Accounts Production 19.4.351 false true false true No description of principal activity 29 January 2025 31 March 2026 31 March 2026 16217765 Dr Olga Khvorostova Dr Takaaki Sato iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16217765 2025-01-28 16217765 2026-03-31 16217765 2025-01-29 2026-03-31 16217765 frs-core:CurrentFinancialInstruments 2026-03-31 16217765 frs-bus:PrivateLimitedCompanyLtd 2025-01-29 2026-03-31 16217765 frs-bus:FilletedAccounts 2025-01-29 2026-03-31 16217765 frs-bus:Micro-entities 2025-01-29 2026-03-31 16217765 frs-bus:AuditExempt-NoAccountantsReport 2025-01-29 2026-03-31 16217765 frs-bus:Director1 2025-01-29 2026-03-31 16217765 frs-bus:Director2 2025-01-29 2026-03-31
Registered number: 16217765
Sora Clinic Ltd
Financial Statements
For the Period 29 January 2025 to 31 March 2026
ACCA
Eden Point
Three Acres Lane
Cheadle
SK8 6RL
Balance Sheet
Registered number: 16217765
31 March 2026
£
Fixed assets 5,541
Current assets 60,357
Creditors: Amounts Falling Due Within One Year (24,654 )
NET CURRENT ASSETS 35,703
TOTAL ASSETS LESS CURRENT LIABILITIES 41,244
Accruals and deferred income (900 )
NET ASSETS 40,344
CAPITAL AND RESERVES 40,344

Notes

1. General Information
Sora Clinic Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16217765 . The registered office is C/O Cutts And Company Eden Point, Three Acres Lane, Cheadle Hulme, Cheadle, SK8 6RL.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Takaaki Sato
Director
28 October 2026